BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

861 related articles for article (PubMed ID: 33563481)

  • 1. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a pediatric monographic hospital in Madrid (Spain).
    Escribano Ceruelo E; Espinel Ruíz MA; Ortega López-Peláez M; Fernández Garoz B; Asensio Antón J; Jiménez García R
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Jan; 40(6):326-9. PubMed ID: 33563481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a pediatric monographic hospital in Madrid (Spain).
    Escribano Ceruelo E; Espinel Ruíz MA; Ortega López-Peláez M; Fernández Garoz B; Asensio Antón J; Jiménez García R
    Enferm Infecc Microbiol Clin (Engl Ed); 2022; 40(6):326-329. PubMed ID: 35501285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.].
    Pérez-García F; Pérez-Zapata A; Arcos Varela N; de la Mata Herrera M; Ortiz García M; Simón Ramos E; Calero Barzano C; Clemente García B; García Miranda L; Martín Soto L; Ropero Martínez M; Barrabés Bayascas RM; Cuadros-González J
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34675168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Hernán MA; Pérez-Olmeda M; Sanmartín JL; Fernández-García A; Cruz I; Fernández de Larrea N; Molina M; Rodríguez-Cabrera F; Martín M; Merino-Amador P; León Paniagua J; Muñoz-Montalvo JF; Blanco F; Yotti R;
    Lancet; 2020 Aug; 396(10250):535-544. PubMed ID: 32645347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital.
    Galán MI; Velasco M; Casas ML; Goyanes MJ; Rodríguez-Caravaca G; Losa-García JE; Noguera C; Castilla V; ;
    Enferm Infecc Microbiol Clin (Engl Ed); 2022; 40(6):302-309. PubMed ID: 35680348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital-Wide SARS-CoV-2 seroprevalence in health care workers in a Spanish teaching hospital.
    Galán MI; Velasco M; Casas ML; Goyanes MJ; Rodríguez-Caravaca G; Losa-García JE; Noguera C; Castilla V; ;
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Dec; 40(6):302-9. PubMed ID: 33485676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.
    Simón Sacristán M; Ybarra de Villavicencio C; Collazos Blanco A; Mayo Montero ME; Ariñez Fernández MDC; Suárez Prieto A; Zamora Cintas MI; Mateo Maestre M
    Curr Microbiol; 2021 Aug; 78(8):2910-2915. PubMed ID: 34156544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
    Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
    Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among hospital workers in a severely affected institution in Madrid, Spain: A surveillance cross-sectional study.
    Pérez-García F; Pérez-Zapata A; Arcos N; De la Mata M; Ortiz M; Simón E; Hervás Fernández I; González Ventosa V; Muñoz Monte M; González Arroyo J; Pérez-Tanoira R; Cuadros-González J
    Infect Control Hosp Epidemiol; 2021 Jul; 42(7):803-809. PubMed ID: 33118904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data.
    Cabezón-Gutiérrez L; Custodio-Cabello S; Palka-Kotlowska M; Oliveros-Acebes E; García-Navarro MJ; Khosravi-Shahi P
    Cancer Treat Rev; 2020 Nov; 90():102102. PubMed ID: 32947121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Serology Testing in an Asymptomatic, At-Risk Population: Methods, Results, Pitfalls.
    Heyming T; Bacon K; Lara B; Knudsen-Robbins C; Tongol A; Sanger T
    Infect Dis Rep; 2021 Oct; 13(4):910-916. PubMed ID: 34698190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV2 Infections in Health Care Personnel in a Long-Term Care Institution After the First Wave of the Pandemic: A Cross-Sectional Study.
    Bautista Balbás LA; Sandino Gómez R; Gil Conesa M; Velasco Guijarro O; Rodríguez Caravaca G; Jou Rivera F; Navasquillo Lorda MÁ; Martín Carmena E
    Workplace Health Saf; 2023 May; 71(5):229-237. PubMed ID: 36708002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 RT-PCR positivity and antibody prevalence among asymptomatic hospital-based health care workers.
    Johnson CC; Coleman CM; Sitarik AR; Leon JE; Tibbetts RJ; Cook BC; Muma BK; Weinmann AJ; Samuel LP
    J Clin Virol; 2021 Jul; 140():104794. PubMed ID: 34023573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.